Responses
Clinical science
Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 8 May 2015
- Published on: 8 May 2015LETTER TO EDITORShow More
We Read with great interest the article Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion by Masahiko Shimura et al.(1) We congratulate the authors for the concept and well conducted pilot study . Repeated intravitreal injections are known to have various complications(2) and it would be safer if noninvasive intervention like topical bromfenac can help to red...
Conflict of Interest:
None declared.